GIDEON OBERIO: Open Payments
NPI 1447951330 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 2 payments from 2 companies in 2025. Trend: 2023 $1,027 · 2024 $1,040 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| ABBVIE INC. | 1 | $17 |
Products named: REXULTI, VRAYLAR.
Industry payments across MD — which companies pay providers there.
